INTEGRA LIFESCIENCES HOLDINGS CORP Payments of Debt Issuance Costs
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Payments of Debt Issuance Costs of $275.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for the quarter ending 2025-12-31 was $134.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for the quarter ending 2025-09-30 was $75.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for the quarter ending 2024-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for fiscal 2025 was $4.06M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for fiscal 2023 was $7.88M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments of debt issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month | Payments of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $275.00K 10-Q · filed 2026-07-29 | ||||
| 2025-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $209.00K derived: sum of 2 quarters · filed 2026-02-26 | $4.06M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.93M 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | $3.85M 10-Q · filed 2026-07-29 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | $301.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $0.00 10-Q · filed 2025-07-31 | $301.00K derived: sum of 3 quarters · filed 2026-02-26 | $301.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 | $301.00K derived: sum of 2 quarters · filed 2026-02-26 | $301.00K derived: sum of 3 quarters · filed 2026-02-26 | $301.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $301.00K derived: sum of 2 quarters · filed 2026-02-26 | $301.00K derived: sum of 3 quarters · filed 2026-02-26 | $7.88M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $7.58M 10-Q · filed 2024-11-04 | $7.58M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $7.58M 10-Q · filed 2024-07-29 | $7.58M derived: sum of 3 quarters · filed 2025-02-25 | $7.58M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $7.58M 10-Q · filed 2024-05-06 | $7.58M derived: sum of 2 quarters · filed 2025-02-25 | $7.58M derived: sum of 3 quarters · filed 2025-02-25 | $7.58M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $0.00 derived: sum of 2 quarters · filed 2023-10-25 | $0.00 10-Q · filed 2023-10-25 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $0.00 10-Q · filed 2023-07-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-04-26 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $249.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $249.00K derived: sum of 3 quarters · filed 2024-02-28 | $249.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $249.00K derived: sum of 2 quarters · filed 2022-10-26 | $249.00K 10-Q · filed 2022-10-26 | $249.00K derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $249.00K 10-Q · filed 2022-07-27 | $249.00K derived: sum of 3 quarters · filed 2023-02-22 | $4.33M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $4.08M derived: sum of 3 quarters · filed 2023-02-22 | $4.08M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $4.08M derived: sum of 2 quarters · filed 2023-02-22 | $4.08M derived: sum of 3 quarters · filed 2023-02-22 | $24.35M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $4.08M derived: sum of 2 quarters · filed 2021-11-02 | $24.35M 10-Q · filed 2021-11-02 | $24.35M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $20.26M 10-Q · filed 2021-07-29 | $20.26M derived: sum of 3 quarters · filed 2022-02-24 | $20.26M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $20.26M 10-Q · filed 2021-04-29 | $20.26M derived: sum of 2 quarters · filed 2022-02-24 | $20.26M derived: sum of 3 quarters · filed 2022-02-24 | $20.26M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $649.00K derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $649.00K derived: sum of 3 quarters · filed 2021-02-23 | $816.00K derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $649.00K derived: sum of 2 quarters · filed 2021-02-23 | $816.00K derived: sum of 3 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $816.00K derived: sum of 2 quarters · filed 2021-02-23 | $5.04M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $4.39M 10-Q · filed 2019-10-25 | |||
| 2018-06-30 | $4.22M 10-Q · filed 2019-07-25 | ||||
| 2017-12-31 | $19.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $19.04M derived: sum of 2 quarters · filed 2020-02-21 | $19.04M 10-K · filed 2020-02-21 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $0.00 10-Q · filed 2018-07-26 | ||||
| 2016-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $4.53M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-10-28 | ||||
| 2015-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.43M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $1.05M 10-Q · filed 2016-10-28 | ||||
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.21M derived: sum of 2 quarters · filed 2017-02-23 | $3.21M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $3.11M 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-05 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $40.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.05M 10-K · filed 2016-02-26 | ||
| 2013-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.05M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $1.01M 10-Q · filed 2014-08-05 | ||||
| 2012-12-31 | $385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $385.00K derived: sum of 2 quarters · filed 2015-02-27 | $385.00K 10-K · filed 2015-02-27 | $0.00 10-K · filed 2013-02-26 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | |||
| 2012-06-30 | $0.00 10-Q/A · filed 2013-08-02 | ||||
| 2011-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $59.00K derived: sum of 2 quarters · filed 2014-06-20 | $8.06M 8-K · filed 2014-06-20 | ||
| 2011-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $8.06M 10-Q · filed 2012-10-24 | |||
| 2011-06-30 | $8.01M 10-Q · filed 2012-07-31 | ||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $6.80M 10-K · filed 2013-02-26 | |||
| 2010-09-30 | $6.80M 10-Q · filed 2011-10-31 | ||||
| 2009-12-31 | $0.00 10-K · filed 2011-02-24 | ||||
| 2008-12-31 | $0.00 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |